Deal could be worth up to $4bn dependent on success milestones
News
Parkinson’s UK partners with UCL on phase II trial
Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s
Evgen scores full approval for COVID-19 trial launch
Investigational drug will be studied as treatment for ARDS in suspected COVID-19 patients
AZ presents new real-world chronic kidney disease data at ASN 2020
Initial key findings from the DISCOVER-Chronic Kidney Disease study revealed
Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs
Agreement will see partners develop SARS-CoV-2 neutralising monoclonal antibodies
BMS partners with Sensyne Health for rare blood disease research
Collaboration will involve applying machine learning for research into rare blood diseases
ICR urges change as NICE rejects Keytruda plus chemotherapy
Keytruda backed for monotherapy treatment but combination therapy rejected
Gilead’s COVID-19 drug remdesivir bags US approval
Antiviral becomes first COVID-19 treatment approved in the US
STORM Therapeutics’ METTL3 inhibitor moves closer to the clinic
First-in-class drug candidate selected for development
Valneva bags positive phase II results for Lyme disease vaccine
Investigational vaccine candidate was generally safe across all dose and age groups
Pharming’s APDS drug scores EU orphan status
European commission grants leniolisib orphan drug designation
Epsilogen awarded £1m grant from Innovate UK
Funding will be used to develop novel IgE antibodies to treat cancer
New research highlights Northern Ireland’s ‘thriving’ life sciences sector
Pharmaceutical and life sciences industries are growing in importance across country
Asthma fund launched to support development and adoption of new technologies
Asthma Technology Fund launched with £3m+ funding
Public urged to follow COVID-19 rules as concerns grow over long-term impact of virus
New film and study highlight the effects of ‘long COVID’
